Literature DB >> 17251329

Standard mutation nomenclature in molecular diagnostics: practical and educational challenges.

Shuji Ogino1, Margaret L Gulley, Johan T den Dunnen, Robert B Wilson.   

Abstract

To translate basic research findings into clinical practice, it is essential that information about mutations and variations in the human genome are communicated easily and unequivocally. Unfortunately, there has been much confusion regarding the description of genetic sequence variants. This is largely because research articles that first report novel sequence variants do not often use standard nomenclature, and the final genomic sequence is compiled over many separate entries. In this article, we discuss issues crucial to clear communication, using examples of genes that are commonly assayed in clinical laboratories. Although molecular diagnostics is a dynamic field, this should not inhibit the need for and movement toward consensus nomenclature for accurate reporting among laboratories. Our aim is to alert laboratory scientists and other health care professionals to the important issues and provide a foundation for further discussions that will ultimately lead to solutions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251329      PMCID: PMC1867422          DOI: 10.2353/jmoldx.2007.060081

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  18 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.

Authors:  Yin Li; Anthony J Raffo; Lisa Drew; Yuehua Mao; Andy Tran; Daniel P Petrylak; Robert L Fine
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

3.  Standardizing mutation nomenclature: why bother?

Authors:  Johan T den Dunnen; Mark H Paalman
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

4.  Importance of standard nomenclature for SMN1 small intragenic ("subtle") mutations.

Authors:  Shuji Ogino; Robert B Wilson
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

5.  Update on nomenclature for human gene mutations. Ad Hoc Committee on Mutation Nomenclature.

Authors: 
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

6.  Genew: the Human Gene Nomenclature Database, 2004 updates.

Authors:  Hester M Wain; Michael J Lush; Fabrice Ducluzeau; Varsha K Khodiyar; Sue Povey
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

7.  The challenge of documenting mutation across the genome: the human genome variation society approach.

Authors:  Ourania Horaitis; Richard G H Cotton
Journal:  Hum Mutat       Date:  2004-05       Impact factor: 4.878

Review 8.  Spinal muscular atrophy: molecular genetics and diagnostics.

Authors:  Shuji Ogino; Robert B Wilson
Journal:  Expert Rev Mol Diagn       Date:  2004-01       Impact factor: 5.225

9.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening.

Authors:  W W Grody; G R Cutting; K W Klinger; C S Richards; M S Watson; R J Desnick
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

10.  Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.

Authors:  Michael S Watson; Garry R Cutting; Robert J Desnick; Deborah A Driscoll; Katherine Klinger; Michael Mennuti; Glenn E Palomaki; Bradley W Popovich; Victoria M Pratt; Elizabeth M Rohlfs; Charles M Strom; C Sue Richards; David R Witt; Wayne W Grody
Journal:  Genet Med       Date:  2004 Sep-Oct       Impact factor: 8.822

View more
  44 in total

1.  A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours.

Authors:  Isabelle Hostein; Maria Debiec-Rychter; Sylvianne Olschwang; Pierre-Paul Bringuier; Louisa Toffolati; David Gonzalez; Sébastien Forget; Fabienne Escande; Lucyna Morzuch; Elena Tamborini; Nicolas Faur; Silvana Pilotti; Paolo Dei Tos; Jean-François Emile; Jean-Michel Coindre
Journal:  J Gastroenterol       Date:  2011-02-01       Impact factor: 7.527

2.  GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.

Authors:  Su Han Lum; Soo Sin Choong; Shekhar Krishnan; Zulqarnain Mohamed; Hany Ariffin
Journal:  Singapore Med J       Date:  2016-06       Impact factor: 1.858

3.  Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U Editing.

Authors:  Philipp Schaefermeier; Sarah Heinze
Journal:  Mol Syndromol       Date:  2016-12-16

Review 4.  Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains.

Authors:  David Monk; Joannella Morales; Johan T den Dunnen; Silvia Russo; Franck Court; Dirk Prawitt; Thomas Eggermann; Jasmin Beygo; Karin Buiting; Zeynep Tümer
Journal:  Epigenetics       Date:  2018-01-25       Impact factor: 4.528

Review 5.  Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.

Authors:  Antonia R Sepulveda; Stanley R Hamilton; Carmen J Allegra; Wayne Grody; Allison M Cushman-Vokoun; William K Funkhouser; Scott E Kopetz; Christopher Lieu; Noralane M Lindor; Bruce D Minsky; Federico A Monzon; Daniel J Sargent; Veena M Singh; Joseph Willis; Jennifer Clark; Carol Colasacco; R Bryan Rumble; Robyn Temple-Smolkin; Christina B Ventura; Jan A Nowak
Journal:  J Mol Diagn       Date:  2017-02-06       Impact factor: 5.568

6.  Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.

Authors:  Takuji Suzuki; Takuro Sakagami; Lisa R Young; Brenna C Carey; Robert E Wood; Maurizio Luisetti; Susan E Wert; Bruce K Rubin; Katharine Kevill; Claudia Chalk; Jeffrey A Whitsett; Carrie Stevens; Lawrence M Nogee; Ilaria Campo; Bruce C Trapnell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

7.  Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

Authors:  Kennichi C Dowdell; Julie E Niemela; Susan Price; Joie Davis; Ronald L Hornung; João Bosco Oliveira; Jennifer M Puck; Elaine S Jaffe; Stefania Pittaluga; Jeffrey I Cohen; Thomas A Fleisher; V Koneti Rao
Journal:  Blood       Date:  2010-04-01       Impact factor: 22.113

Review 8.  Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway.

Authors:  Dengliang Huang; Yiting Wang; Jiabin Tang; Shiwen Luo
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

9.  Locus Reference Genomic sequences: an improved basis for describing human DNA variants.

Authors:  Raymond Dalgleish; Paul Flicek; Fiona Cunningham; Alex Astashyn; Raymond E Tully; Glenn Proctor; Yuan Chen; William M McLaren; Pontus Larsson; Brendan W Vaughan; Christophe Béroud; Glen Dobson; Heikki Lehväslaiho; Peter Em Taschner; Johan T den Dunnen; Andrew Devereau; Ewan Birney; Anthony J Brookes; Donna R Maglott
Journal:  Genome Med       Date:  2010-04-15       Impact factor: 11.117

10.  Carrier frequency of GJB2 (connexin-26) mutations causing inherited deafness in the Korean population.

Authors:  Sung-Hee Han; Hong-Joon Park; Eun-Joo Kang; Jae-Song Ryu; Anna Lee; Young-Ho Yang; Kyoung-Ryul Lee
Journal:  J Hum Genet       Date:  2008-12-02       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.